Paediatric Hematology Oncology Unit, "Policlinico-Giovanni XXII" Hospital, University of Bari, Italy.
Pediatric Immunology Unit "Anna Meyer" Hospital University of Florence, Italy.
Vaccine. 2018 Jun 7;36(24):3541-3554. doi: 10.1016/j.vaccine.2018.01.061. Epub 2018 Feb 6.
Infectious complications are a major cause of morbidity and mortality in patients with primary or secondary immunodeficiency. Prevention of infectious diseases by vaccines is among the most effective healthcare measures mainly for these subjects. However immunocompromised people vary in their degree of immunosuppression and susceptibility to infection and, therefore, represent a heterogeneous population with regard to immunization. To date there is no well- established evidence for use of vaccines in immunodeficient patients, and indications are not clearly defined even in high-quality reviews and in most of the guidelines prepared to provide recommendations for the active vaccination of immunocompromised hosts. The aim of this document is to issue recommendations based on published literature and the collective experience of the Italian primary immunodeficiency centers, about how and when vaccines can be used in immunocompromised patients, in order to facilitate physician decisions and to ensure the best immune protection with the lowest risk to the health of the patient.
感染性并发症是原发性或继发性免疫缺陷患者发病和死亡的主要原因。疫苗预防传染病是针对这些患者的最有效医疗措施之一。然而,免疫功能低下患者的免疫抑制程度和感染易感性存在差异,因此在免疫接种方面具有异质性。迄今为止,尚无充分证据支持在免疫缺陷患者中使用疫苗,即使在高质量的综述和大多数旨在为免疫功能低下宿主主动接种疫苗提供建议的指南中,疫苗的适应证也没有明确界定。本文件的目的是根据已发表的文献和意大利原发性免疫缺陷中心的集体经验,就如何以及何时可以在免疫功能低下患者中使用疫苗提出建议,以方便医生做出决策,并确保患者获得最佳免疫保护,同时将风险降至最低。